HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3-methylsydnone-5-nitrosimine

structure given in first source

Also Known As:

RE 2047; RE-2047

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Oxazoles: 89
      - Oxadiazoles: 146
        Sydnones: 2
        3-methylsydnone-5-nitrosimine: 4

Experts

1.	Brune, K: 1 article (02/2001)
2.	Geisslinger, G: 1 article (02/2001)
3.	Gühring, H: 1 article (02/2001)
4.	Lötsch, J: 1 article (02/2001)
5.	Pahl, A: 1 article (02/2001)
6.	Reeh, P W: 1 article (02/2001)
7.	Rehse, K: 1 article (02/2001)
8.	Tegeder, I: 1 article (02/2001)
9.	Werner, U: 1 article (02/2001)

Related Diseases

1.	Thrombosis (Thrombus) 05/01/1999 - "However, it enhanced the inhibition of thrombus formation by RE 2047 from 9% to 17% (5 + 5 mg/kg) or 19% to 27% (10 + 10 mg/kg) in arterioles. " 01/01/1995 - "The combination of 10 mg/kg RE 2047 with the same dose of ASA in arterioles (A) showed 70% inhibition of thrombosis (venoles (V): 40%). " 01/01/1995 - "The combined effects of the NO-donor RE 2047 with ASA, pentoxifylline, ticlopidine or BM 14515 were determined in vitro (Born-test) and in vivo (rat thrombosis model). " 04/01/1995 - "The combined effects of the oligoamine RE 1492 with the NO-donor RE 2047 or ASA, ticlopidine, pentoxifylline and BM 14515 were determined in vitro (Born-test) and in vivo (rat thrombosis model). "
2.	Hyperalgesia 02/01/2001 - "In addition, the effects of the iNOS inhibitor L-NIL on inflammatory paw edema and thermal hyperalgesia were studied in comparison to those of the NO-donor RE-2047. "
3.	Edema (Dropsy) 02/01/2001 - "In addition, the effects of the iNOS inhibitor L-NIL on inflammatory paw edema and thermal hyperalgesia were studied in comparison to those of the NO-donor RE-2047. "

Related Drugs and Biologics

1.	Ticlopidine (Ticlid)
2.	Pentoxifylline (Trental)
3.	N(6)-(1-iminoethyl)lysine
4.	RE 1492